Kayentis

📍 Meylan, France🗓 Founded 2003👥 170 employees💰 Last funded Apr 2017
Pharmaceutical Manufacturing🌐 kayentis.com
Website LinkedIn
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2003, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases II/III across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 280 clinical trials in 85 countries (18,000 sites and 98,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2003
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Kayentis?
Kayentis has 2 investors on record on gritt.io.
When did Kayentis last raise funding?
The most recent investment in Kayentis recorded on gritt.io was in April 2017.
When was Kayentis founded?
Kayentis was founded in 2003.
What industry is Kayentis in?
Kayentis operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Kayentis based?
Kayentis is headquartered in Meylan, France.